cytarabine has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, XZ; Huang, YQ; Pan, JX; Wu, SX; Zhang, XY | 1 |
| Al-Malki, H; Cebrian-Silla, A; Fehse, B; Fransen, NL; Garcia-Verdugo, JM; Gomez-Nicola, D; Perry, VH; Riecken, K; Suzzi, S; Vargas-Caballero, M | 1 |
| Ishitani, R; Katsube, N; Kuwae, T; Sunaga, K; Tajima, H; Takahashi, H; Tsuchiya, K; Yamada, M | 1 |
| Parshad, R; Price, FM; Sanford, KK; Schapiro, MB; Tarone, RE | 1 |
| Melnick, LK; Nee, LE; Parshad, RP; Price, FM; Robbins, JH; Sanford, KK; Schapiro, MB; Tarone, RE | 1 |
| Parshad, R; Price, FM; Sanford, KK; Schapiro, MB | 1 |
6 other study(ies) available for cytarabine and Alzheimer Disease
| Article | Year |
|---|---|
[Curative Effect of Decitabine Combined with IAG Regimen for Senile Patients with Myelodysplastic Syndrome (MDS) Transformed Acute Myeloid Leukemia].
Topics: Alzheimer Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Decitabine; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Treatment Outcome | 2017 |
Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.
Topics: Adult; Aged; Alzheimer Disease; Animals; Antimetabolites, Antineoplastic; Cell Proliferation; Chronic Disease; Creutzfeldt-Jakob Syndrome; Cytarabine; Dentate Gyrus; Disease Models, Animal; Disease Progression; Female; Genetic Vectors; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mossy Fibers, Hippocampal; Neural Pathways; Neural Stem Cells; Neuroanatomical Tract-Tracing Techniques; Neurodegenerative Diseases; Neurogenesis; Patch-Clamp Techniques; Prion Diseases; Prions; Time Factors; Tissue Banks; Young Adult | 2014 |
Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Apoptosis; Cell Nucleus; Cells, Cultured; Cerebellum; Cloning, Molecular; Cytarabine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Middle Aged; Molecular Sequence Data; Nootropic Agents; Prefrontal Cortex; Promoter Regions, Genetic; Rats; Transfection | 2004 |
X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness.
Topics: Adult; Aged; Alzheimer Disease; Cell Cycle; Chromatids; Cytarabine; DNA Damage; DNA Repair; Down Syndrome; Female; Humans; In Vitro Techniques; Interphase; Male; Middle Aged; Neoplasms; X-Rays | 1993 |
Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture.
Topics: Alzheimer Disease; Caffeine; Case-Control Studies; Cells, Cultured; Chromatids; Cytarabine; DNA; DNA Damage; DNA Repair; Down Syndrome; Female; Fibroblasts; G1 Phase; G2 Phase; Humans; Light; Lymphocytes; Male; Ultraviolet Rays | 1996 |
Effect of DNA repair inhibitors on the in vitro test for Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Antimetabolites, Antineoplastic; Cells, Cultured; Chromatids; Chromosome Breakage; Cytarabine; DNA Damage; DNA Repair; Down Syndrome; Female; Humans; Light; Male; Middle Aged | 1998 |